TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16230074

Group type: EXPERIMENTAL
Intervention: Entecavir 1.0 mg daily
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Entecavir 0.5 mg daily
Number of subjects: 182

Group type: COMPARATOR
Intervention: Lamivudine 100 mg daily
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Entecavir 0.1 mg daily
Number of subjects: 182
Study: 12123333

Group type: EXPERIMENTAL
Intervention: Intramuscular depot medroxyprogesterone acetate (MPA) 500 mg on days 1, 14, and 28
Number of subjects: 71

Group type: COMPARATOR
Intervention: Oral megestrol acetate 40 mg daily for 6 weeks
Number of subjects: 71
Study: 9498941

Group type: EXPERIMENTAL
Intervention: Proventil HFA
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ventolin
Number of subjects: 0

Group type: COMPARATOR
Intervention: HFA‐134a placebo
Number of subjects: 0
Study: 7836079

Group type: COMPARATOR
Intervention: Accelerated radiotherapy 60 Gy in 30 fractions in 3 weeks (arm II)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Radiotherapy 60 Gy in 30 fractions in 6 weeks (arm I)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Radiotherapy 60 Gy in 30 fractions in 6 weeks plus carboplatin 350 mg/m2 during weeks 1 and 5 (arm III)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Accelerated radiotherapy 60 Gy in 30 fractions in 3 weeks plus carboplatin 350 mg/m2 during week 1 (arm IV)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: All treatment arms
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Accelerated radiotherapy
Number of subjects: 100
Study: 2136775

Group type: EXPERIMENTAL
Intervention: Nebulised ipratropium bromide plus 4‐hourly fenoterol (group I, 50 patients)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: 2‐hourly fenoterol (group II, 50 patients)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: 4‐hourly fenoterol (group III, 45 patients)
Number of subjects: 145
Study: 30787234

Group type: EXPERIMENTAL
Intervention: Early post-pyloric feeding (EPF)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Delayed post-pyloric feeding (DPF)
Number of subjects: 13
Study: 28391910

Group type: EXPERIMENTAL
Intervention: Soy diet
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Nonsoy plant diet
Number of subjects: 173

Group type: COMPARATOR
Intervention: Dairy diet
Number of subjects: 173

Group type: COMPARATOR
Intervention: Animal diet
Number of subjects: 173
Study: 26389597

Group type: EXPERIMENTAL
Intervention: Cognitive therapy plus memory support (CT + MS; n = 22)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Cognitive therapy as-usual (CT-as-usual; n = 20)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Cognitive therapy plus memory support (CT + MS)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Cognitive therapy as-usual (CT-as-usual)
Number of subjects: 42
Study: 24406614

Group type: EXPERIMENTAL
Intervention: Scopolamine transdermal patch, dosage and duration not specified
Number of subjects: 0
Study: 23031065

Group type: EXPERIMENTAL
Intervention: Exercise prescription (individually tailored home-based exercise prescriptions for 6 months)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Baseline physical activity levels
Number of subjects: 83
Study: 20826257

Group type: EXPERIMENTAL
Intervention: Telmisartan (40 mg/d; TEL, n = 25)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo (PLA, n = 24)
Number of subjects: 49
Study: 17519582

Group type: EXPERIMENTAL
Intervention: Tomato extract (TE) 360 mg per day for 8 weeks
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 15674509

Group type: EXPERIMENTAL
Intervention: Fentanyl and propofol TCI (group FP)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Fentanyl and less than 1% sevoflurane (group Fs)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Sevoflurane (group S)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Comparison between group FP and group Fs
Number of subjects: 75
Study: 11880015

Group type: EXPERIMENTAL
Intervention: Perioperative platelet plasmapheresis (APP group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 10434817

Group type: EXPERIMENTAL
Intervention: Patient-controlled epidural fentanyl (PCEF)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Patient-controlled i.v. morphine (PCIM)
Number of subjects: 84
Study: 7877647

Group type: COMPARATOR
Intervention: Mastectomy
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Lumpectomy plus radiation
Number of subjects: 247
Study: 1977703

Group type: EXPERIMENTAL
Intervention: H2-receptor antagonists (cimetidine, ranitidine, famotidine, nizatidine)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Proton pump inhibitor (omeprazole)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Antacids
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Lifestyle changes
Number of subjects: 60
Study: 82356

Group type: EXPERIMENTAL
Intervention: 0.6 g of oral zinc sulphate daily
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 31846745

Group type: EXPERIMENTAL
Intervention: Taping
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Elastic bandaging
Number of subjects: 68

Group type: COMPARATOR
Intervention: Both interventions (taping and elastic bandaging)
Number of subjects: 68
Study: 30525306

Group type: EXPERIMENTAL
Intervention: Electronic standardized nursing care plans (SNCPs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Paper-based standardized nursing care plans (SNCPs)
Number of subjects: 0
Study: 28425966

Group type: EXPERIMENTAL
Intervention: Glucose-Fructose (GF)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Water (C)
Number of subjects: 16
Study: 24918475

Group type: EXPERIMENTAL
Intervention: 2.0 mL oral 24% sucrose (n=29)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Sterile water (n=27)
Number of subjects: 56
Study: 23537606

Group type: EXPERIMENTAL
Intervention: Joint Crisis Plans (JCPs)
Number of subjects: 569

Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 569
Study: 21665899

Group type: EXPERIMENTAL
Intervention: Desflurane at 1.5 MAC
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Isoflurane at 1.5 MAC
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Sevoflurane at 1.5 MAC
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Desflurane at 1 MAC
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Isoflurane at 1 MAC
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Sevoflurane at 1 MAC
Number of subjects: 71
Study: 19192993

Group type: EXPERIMENTAL
Intervention: Single-day famciclovir (1 g twice-daily)
Number of subjects: 1179

Group type: COMPARATOR
Intervention: 3-day valacyclovir (500 mg twice-daily)
Number of subjects: 1179

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 1179
Study: 17196793

Group type: EXPERIMENTAL
Intervention: Levetiracetam 1g/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Levetiracetam 2g/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Levetiracetam 3g/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Levetiracetam 4g/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 14716727

Group type: EXPERIMENTAL
Intervention: Odds Ratio (OR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Receiver Operating Characteristic (ROC) methods
Number of subjects: 0

Group type: COMPARATOR
Intervention: Success rates in treatment and control groups
Number of subjects: 0

Group type: COMPARATOR
Intervention: Number needed to treat (NNT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intraclass kappa
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Weighted kappa
Number of subjects: 0
Study: 11471927

Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg once daily in the evening (n = 15)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo (n = 7)
Number of subjects: 22
Study: 9035016

Group type: EXPERIMENTAL
Intervention: etodolac 150 mg bid
Number of subjects: 1446

Group type: EXPERIMENTAL
Intervention: etodolac 500 mg bid
Number of subjects: 1446

Group type: COMPARATOR
Intervention: ibuprofen 600 mg qid
Number of subjects: 1446
Study: 7942046

Group type: EXPERIMENTAL
Intervention: Type I fibre proportion (type I%) in women and men
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Maximal oxygen uptake (VO2max)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Running performance (9 min endurance test)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Strength tests (Sargent jump, handgrip test, two-hand lift)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Activity index from questionnaire
Number of subjects: 83
Study: 3428339

Group type: EXPERIMENTAL
Intervention: Oxitropium Bromide (OTB)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31610100

Group type: EXPERIMENTAL
Intervention: IV tramadol 50 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IV tramadol 75 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral tramadol 100 mg
Number of subjects: 0
Study: 29358423

Group type: EXPERIMENTAL
Intervention: internet-based perioperative care programme
Number of subjects: 433

Group type: COMPARATOR
Intervention: usual care
Number of subjects: 433
Study: 28583289

Group type: EXPERIMENTAL
Intervention: ATLG
Number of subjects: 202

Group type: COMPARATOR
Intervention: non-ATLG
Number of subjects: 202
Study: 26645271

Group type: EXPERIMENTAL
Intervention: Phosphate binder therapy taken with meals
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard prescription of phosphate binders
Number of subjects: 60
Study: 24146510

Group type: EXPERIMENTAL
Intervention: General acteoside of Rehmanniae leaves (two 200mg tablets, bid)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Piperazine ferulate (four 50-mg tablets, bid)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: General acteoside of Rehmanniae leaves
Number of subjects: 400

Group type: COMPARATOR
Intervention: Piperazine ferulate
Number of subjects: 400
Study: 21348543

Group type: EXPERIMENTAL
Intervention: Narrow-band UVB treatment in vitiligo-melasma group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Narrow-band UVB treatment in vitiligo group
Number of subjects: 0
Study: 18364505

Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy (HT)
Number of subjects: 442

Group type: COMPARATOR
Intervention: Best management without hormones (Control)
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: HT
Number of subjects: 442

Group type: COMPARATOR
Intervention: Control
Number of subjects: 442
Study: 17166808

Group type: EXPERIMENTAL
Intervention: Dynamic balance training using commercially available balance training mechanical apparatus
Number of subjects: 16

Group type: COMPARATOR
Intervention: Physically managed by a physiotherapist (Control)
Number of subjects: 16
Study: 15117001

Group type: EXPERIMENTAL
Intervention: Font presented with 1 word during study
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Font presented with 20 words during study
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-frequency fonts
Number of subjects: 0
Study: 11351939

Group type: EXPERIMENTAL
Intervention: Tryptophan depletion
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 9429329

Group type: EXPERIMENTAL
Intervention: Dilatation
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Internal Urethrotomy
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Both
Number of subjects: 210
Study: 8105717

Group type: EXPERIMENTAL
Intervention: Clonidine (4 micrograms/kg body weight)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Clonidine (1 mg/kg propofol)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Clonidine (1.5 mg/kg propofol)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Clonidine (2 mg/kg propofol)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (1 mg/kg propofol)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (1.5 mg/kg propofol)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (2 mg/kg propofol)
Number of subjects: 100
Study: 3305087

Group type: EXPERIMENTAL
Intervention: Gossypol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29315132

Group type: EXPERIMENTAL
Intervention: Self-help cognitive behavior therapy (SH-CBT)
Number of subjects: 124

Group type: COMPARATOR
Intervention: No treatment waitlist control (NTWC)
Number of subjects: 124
Study: 27050189

Group type: EXPERIMENTAL
Intervention: IV metoprolol (2 × 5-mg bolus)
Number of subjects: 683

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 683
Study: 24988513

Group type: EXPERIMENTAL
Intervention: Patient education with telephone follow-up on wound care and clean dressing technique at home.
Number of subjects: 126

Group type: COMPARATOR
Intervention: Normal wound care (sterile dressing changes by professional nurses in a nonspecialized outpatient clinic).
Number of subjects: 126
Study: 22280501

Group type: EXPERIMENTAL
Intervention: Whole systems model of self-management support
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 20862941

Group type: EXPERIMENTAL
Intervention: Moxibustion
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hot compress
Number of subjects: 60

Group type: COMPARATOR
Intervention: Infrared irradiation
Number of subjects: 60
Study: 18420531

Group type: EXPERIMENTAL
Intervention: Pegloticase 4 mg every 2 weeks
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Pegloticase 8 mg every 2 weeks
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Pegloticase 8 mg every 4 weeks
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Pegloticase 12 mg every 4 weeks
Number of subjects: 40
Study: 16105815

Group type: EXPERIMENTAL
Intervention: Propofol 2 mg.kg(‐1) iv
Number of subjects: 40

Group type: COMPARATOR
Intervention: Thiopental 5 mg.kg(‐1) iv
Number of subjects: 40
Study: 14520853

Group type: EXPERIMENTAL
Intervention: Combined psychocorrection including neuroleptic trifluoperasine and psychorelaxation therapy
Number of subjects: 132
Study: 10588623

Group type: COMPARATOR
Intervention: Pulmonary Rehabilitation
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Bilateral Lung Volume Reduction Surgery (LVRS)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Quality of Life (Sickness Impact Profile)
Number of subjects: 200
Study: 7486181

Group type: EXPERIMENTAL
Intervention: Epidural anesthesia
Number of subjects: 12
Study: 2572248

Group type: EXPERIMENTAL
Intervention: Cimetidine 400 mg
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Ranitidine 80 mg
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Famotidine 20 mg
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 70
Study: 5571451

Group type: EXPERIMENTAL
Intervention: Pethidine + Entonox
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Pethidine + Trichloroethylene
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Pethidine alone
Number of subjects: 152
Study: 30554749

Group type: EXPERIMENTAL
Intervention: IYCF (20 g of a small‐quantity lipid‐based nutrient supplement per day from age 6 to 18 months plus complementary feeding counselling)
Number of subjects: 3686

Group type: EXPERIMENTAL
Intervention: IYCF
Number of subjects: 3686

Group type: COMPARATOR
Intervention: WASH (construction of a ventilated improved pit latrine, provision of two handwashing stations, liquid soap, chlorine, and play space plus hygiene counselling)
Number of subjects: 3686

Group type: EXPERIMENTAL
Intervention: IYCF plus WASH
Number of subjects: 3686

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 3686
Study: 27625314

Group type: EXPERIMENTAL
Intervention: Slideshows with voice-over
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Animated videos
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Comics
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Text
Number of subjects: 1500

Group type: COMPARATOR
Intervention: No-intervention control
Number of subjects: 1500
Study: 25442673

Group type: EXPERIMENTAL
Intervention: McKenzie techniques
Number of subjects: 70

Group type: COMPARATOR
Intervention: Motor control exercises
Number of subjects: 70
Study: 23674606

Group type: EXPERIMENTAL
Intervention: HFrEx (30% fructose diet with moderate aerobic exercise)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: HFr (30% fructose diet with no exercise)
Number of subjects: 8

Group type: COMPARATOR
Intervention: C (low fructose diet with no exercise)
Number of subjects: 8
Study: 21292262

Group type: EXPERIMENTAL
Intervention: Endoscopic resection (ER) followed by radiofrequency ablation (RFA)
Number of subjects: 26
Study: 19972662

Group type: EXPERIMENTAL
Intervention: Embedded narrative
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: Traditional narrative
Number of subjects: 311

Group type: COMPARATOR
Intervention: Expository
Number of subjects: 311

Group type: COMPARATOR
Intervention: No viewing
Number of subjects: 311
Study: 17554644

Group type: COMPARATOR
Intervention: Music therapy (group A, no pharmacotherapy)
Number of subjects: 641

Group type: COMPARATOR
Intervention: Music therapy (group B, with pharmacotherapy)
Number of subjects: 641
Study: 15525790

Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 100

Group type: COMPARATOR
Intervention: Disulfiram
Number of subjects: 100
Study: 11444448

Group type: EXPERIMENTAL
Intervention: Preoperative periportal bupivacaine and intraperitoneal bupivacaine immediately after pneumoperitoneum (Group A)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Periportal and intraperitoneal bupivacaine at the end of the operation (Group B)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Preoperative periportal bupivacaine (Group C)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Postoperative periportal bupivacaine (Group D)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Preoperative intraperitoneal bupivacaine (Group E)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Postoperative intraperitoneal bupivacaine (Group F)
Number of subjects: 157

Group type: COMPARATOR
Intervention: No treatment (Control Group)
Number of subjects: 157
Study: 9919837

Group type: EXPERIMENTAL
Intervention: Uncoated theophylline tablet (200 mg, 300 mg dose 5 mg/kg approx) administered orally after 12 hours overnight fasting
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (well-nourished asthma patients)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Comparison between undernourished and well-nourished asthma patients
Number of subjects: 24
Study: 7850231

Group type: EXPERIMENTAL
Intervention: Fluorescent method
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bromocresol purple method
Number of subjects: 0
Study: 3299681

Group type: EXPERIMENTAL
Intervention: Auranofin (AF) oral gold
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29217495

Group type: EXPERIMENTAL
Intervention: Violet oil
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Almond oil
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 26371345

Group type: EXPERIMENTAL
Intervention: 13.3 mg/24 h rivastigmine patch
Number of subjects: 0

Group type: COMPARATOR
Intervention: 4.6 mg/24 h rivastigmine patch
Number of subjects: 0
Study: 25478898

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy
Number of subjects: 12
Study: 22249909

Group type: EXPERIMENTAL
Intervention: Therapeutic hyperoxia (FiO2 0.28)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (FiO2 0.21)
Number of subjects: 16
Study: 19745744

Group type: EXPERIMENTAL
Intervention: 1-year intradialytic exercise training program (group A)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (group B)
Number of subjects: 44
Study: 18513359

Group type: EXPERIMENTAL
Intervention: Alcohol
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Alcohol and Placebo
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 0.1-Hz HRV index
Number of subjects: 36
Study: 18212313

Group type: COMPARATOR
Intervention: Radiation therapy (RT) alone
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Radiation therapy (RT) and androgen suppression therapy (AST) combined
Number of subjects: 206

Group type: COMPARATOR
Intervention: RT alone in men with no or minimal comorbidity
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: RT and AST in men with no or minimal comorbidity
Number of subjects: 206

Group type: COMPARATOR
Intervention: RT alone in men with moderate or severe comorbidity
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: RT and AST in men with moderate or severe comorbidity
Number of subjects: 206
Study: 15305182

Group type: EXPERIMENTAL
Intervention: Interferon‐alpha (INFalpha) 2a, 4.5 mega‐units subcutaneously 3 days per week
Number of subjects: 300

Group type: COMPARATOR
Intervention: No further treatment (Control)
Number of subjects: 300
Study: 11404442

Group type: EXPERIMENTAL
Intervention: Patients with ventromedial prefrontal cortex lesions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patients with dorsolateral lesions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Explicit measures (questionnaires)
Number of subjects: 0
Study: 9348687

Group type: EXPERIMENTAL
Intervention: Primary-signal trials where a fixed primary signal was added to one component of the complex tone.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Probe signal added to the cued component or to one of three other components in randomized spectral profile trials.
Number of subjects: 0
Study: 8325398

Group type: EXPERIMENTAL
Intervention: timolol 0.25%
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: timolol 0.5%
Number of subjects: 40
Study: 3518911

Group type: EXPERIMENTAL
Intervention: Amputation
Number of subjects: 211

Group type: COMPARATOR
Intervention: Limb-sparing procedures plus postoperative radiotherapy
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Local excision
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy in a randomized trial
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Surgical intervention for recurrent disease
Number of subjects: 211